Chronic kidney disease (CKD) is a global health burden with a high economic cost to health
systems and is an independent risk factor for cardiovascular disease (CVD). All stages of …

Chronic kidney disease (CKD) is currently defined by abnormalities of kidney structure or
function assessed using a matrix of variables—including glomerular filtration rate (GFR) …

Chronic kidney disease (CKD) is fast becoming a major public health issue,
disproportionately burdening low-income to middle-income countries, where detection rates …

Elevated serum uric acid levels are a frequent finding in persons with obesity, hypertension,
cardiovascular and kidney disease as well as in those with the cardiorenal metabolic …

Zdrojewski et al. present a survey assessing the prevalence of albuminuria and renal
dysfunction in a representative sample of the adult Polish population. This survey …

Patients affected by chronic kidney disease (CKD) or end-stage renal disease (ESRD)
experience a huge cardiovascular risk and cardiovascular events represent the leading …

Importance The efficacy of folic acid therapy on renal outcomes has not been previously
investigated in populations without folic acid fortification. Objective To test whether treatment …

Abstract Background: Hyperhomocysteinemia (Hhcy) occurs in about 85% of chronic kidney
disease (CKD) patients because of impaired renal metabolism and reduced renal excretion …

Hyperhomocysteinemia (HHcy) is a risk factor for chronic kidney diseases (CKDs) that
affects about 85% CKD patients. HHcy stimulates B cells to secrete pathological antibodies …

Background National surveys in countries outside Europe have reported a high prevalence
(11–13%) of chronic kidney disease (CKD). Studies in Europe have provided a variable …